MARCH 2012: DRUG APPROVALS
MARCH 1: Viokace (pancrelipase) Tablets
Treatment- Pancreatic Exocrine Dysfunction
MARCH 1: Ultresa (pancrelipase) Delayed Release Capsules
Treatment- Pancreatic Exocrine Dysfunction
MARCH 6: Surfaxin (lucinactant)
Treatment- Respiratory Distress Syndrome
